Tumours producing hypoglycaemia

Endocrine-Related Cancer

Volumn 5, Issue 2, 1998, Pages 111-129

  Marks, V ^a   Teale, J D ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; INSULIN; PROINSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

CATECHOLAMINE RELEASE; ECTOPIC HORMONE PRODUCTION; FIBROMA; FIBROSARCOMA; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; HYPOPITUITARISM; INSULIN RELEASE; INSULINOMA; LEUKEMIA; LIVER CELL CARCINOMA; LYMPHOMA; MYELOMA; PATHOPHYSIOLOGY; REVIEW; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 0031806733     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0050111     Document Type: Review

References (176)

1. Agus MSD, Levit Katz LE, Satin-Smith M, Meadows AT, Hintz RL & Cohen P 1995 Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone. Journal of Pediatrics 127 403-407.
2. Akiba M, Kodama T, Ito Y, Obara T & Fujimoto Y 1990 Hypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma. World Journal of Surgery 14 316-324.
3. Alberts AS & Falkson G 1988 Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide): a case report. Journal of South African Medicine 74 75-76.
4. Alsever RN, Roberts JP, Gerber JG, Mako ME & Rubenstein AH 1975 Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements. Annals of Internal Medicine 82 347-350.
5. Arnqvist HJ, Halban PA, Mathiesen UL, Zahnd G & von Schenck H 1993 Hypoglycaemia caused by atypical insulin antibodies in a patient with benign monoclonal gammopathy. Journal of Internal Medicine 234 421-427.
6. Astles JR, Petros WP, Peters WP & Sedor FA 1995 Artifactual hypoglycemia associated with hematopoietic cytokines. Archives of Pathological Laboratory Medicine 119 713-716.
7. Atkinson AB, Hadden DR, Kennedy TL, Montgomery DAD, McIlrath E & Weaver JA 1981 Insulinomas in Northern Ireland between 1960 and 1980. Ulster Medical Journal 50 21-32.
8. Axelrod L & Ron D 1988 Insulin-like growth factor II and the riddle of tumor-induced hypoglycemia. New England Journal of Medicine 319 1477-1479.
9. Baltic V, Levanat S, Petck M, Bratic-Mikes V, Pavelic K & Vuk-Pavlovic S 1985 Elevated levels of substances immunologically cross-reactive with insulin in blood of patients with malignant and nonmalignant pulmonary tissue proliferation. Oncology 42 174-178.
10. Barzilai N, Cohen P, Barillan R, McIntyre N & Karnieli E 1991 Case report - increased insulin sensitivity in tumor hypoglycemia in a diabetic patient - glucose metabolism in tumor hypoglycemia. American Journal of the Medical Sciences 302 229-234.
11. Battelino T, Goto M & Zeller WP 1996 Dexamethasone attenuates hypoglycemia in ten day old rats treated with TNF alpha. Research Communications in Molecular Pathology and Pharmacology 92 149-154.
12. Baxter RC 1990 Radioimmunoassay for insulin-like growth factor (IGF)-II: interference by pure IGF-binding proteins. Journal of Immunoassay 11 445-458.
13. Baxter RC 1996 The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. Hormone Research 46 195-201.
14. Baxter RC & Martin JL 1989 Binding proteins for the insulin-like growth factors: structure, regulation and function. Progress in Growth Factor Research 1 49-68.
15. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ & Braund W 1995 Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism 80 2700-2708.
16. Berger M, Bordi C, Cuppers H-J, Berchthold P & Gries FA 1983 Functional and morphologic characterization of human insulinomas. Diabetes 32 921-931.
17. Bottger TC, Weber W, Beyer J & Junginger T 1990 Value of tumor localization in patients with insulinoma. World Journal of Surgery 14 107-112.
18. Braund WJ, Naylor BA, Williamson DH, Bailey ID, Clark A, Chapel HM & Turner RC 1987 Autoimmunity to insulin receptor and hypoglycaemia in patients with Hodgkin's disease. Lancet i 237-240.
19. Bruno MS & Ober WB 1962 Hypoglycemia and intrathoracic mass. New York State Journal of Medicine 62 2005-2008.
20. Bugalho MJ, Roque L, Sobrinho LG, Hoog A, Nunes JF, Almeida JM, Leitao CN & Santos JR 1994 Calcitonin-producing insulinoma: clinical, immunocytochemical and cytogenetical study. Clinical Endocrinology 41 257-260.
21. Chang HY, Huang HS, Lin JD, Huang BY, Huang MJ & Jeng LB 1994 Insulinoma - clinical experience in ten cases. Chang Keng I Hsueh 17 28-38.
22. Chiang WL, Tsai MH, Lieu CS, Yang SF & Lin PC 1993 Postoperative hypoglycemia after pheochromocytoma resection (Chinese). Ma-Tsui-Hsueh-Tsa-Chi 31 273-276.
23. Chung J & Henry RR 1996 Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. Journal of Clinical Endocrinology and Metabolism 81 919-925.
24. Clark IA, Gray KM, Rockett EJ, Cowden WB, Rockett KA, Ferrante A & Aggarwal BB 1992 Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Transactions of the Royal Society of Tropical Medicine and Hygiene 86 602-607.
25. Clemmons DR 1989 Structural and functional analysis of insulinlike growth factors. British Medical Bulletin 45 465-480.
26. Cohen RM & Camus F 1988 Update on insulinomas or the case of the missing (pro)insulinoma. Diabetes Care 11 506-507.
27. Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS & Rubenstein AH 1986 Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism 35 1137-1146.
28. Coskey RL & Tranquada RE 1964 Insulinoma and multiple neurofibromatosis. Metabolism 13 312-324.
29. Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke V, Frerichs H & Track NS 1973 Biochemical and morphological investigations of 30 human insulinomas. Diabetologia 9 217-231.
30. Crowley PF, Slavin JL & Rode-J 1996 Massive amyloid deposition in pancreatic vipoma: a case report. Pathology 28 377-379.
31. Cullen RM & Ong CE 1987 Insulinoma in Auckland 1970-1985. New Zealand Medical Journal 100 560-562.
32. Daggett PR, Goodburn EA, Kurtz AB, Le Quesne LP, Morris DV, Nabarro JDN & Raphael MJ 1981 Is preoperative localisation of insulinomas necessary? Lancet i 483-486.
33. Daughaday WH 1989 Hypoglycemia in patients with non-islet cell tumors. Endocrinology and Metabolism Clinics of North America 18 91-98.
34. Daughaday WH 1997 Insulin-like growth factors and tumour hypoglycaemia. In Clinical Endocrine Oncology, pp 496-501. Eds R Sheaves, PJ Jenkins & JAH Wass. Oxford: Blackwell Science.
35. Daughaday WH & Kapadia M 1989 Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proceedings of the National Academy of Sciences of the USA 86 6778-6782.
36. Daughaday WH & Trivedi B 1992 Measurement of derivatives of proinsulin-like growth factor II in serum by a radio-immunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism 75 110-115.
37. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M & Rotwein P 1988 Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. New England Journal of Medicine 319 1434-1440.
38. Daughaday WH, Wu J-C, Lee S-D & Kapadia M 1990 Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus antibody-positive asymptomatic individuals. Journal of Laboratory and Clinical Medicine 116 555-562.
39. Diarmuid S, O'Riordain MB, O'Brien T, van Heerden JA, Service FJ & Grant CS 1994 Surgical management of insulinoma associated with multiple endocrine neoplasia Type I. World Journal of Surgery 18 488-494.
40. Doherty GM, Doppman JL, Shawker TH, Miller DL, Eastman RC, Corden P & Norton JA 1991 Results of a prospective strategy to diagnose, localize and resect insulinomas. Surgery 110 989-996.
41. Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, Collier E, Skarulis MC & Corden P 1995 Localization of insulinomas in regions of the pancreas by infra-arterial stimulation with calcium. Annals of Internal Medicine 123 269-273.
42. Dunn DC 1971 Diabetes after removal of insulin tumours of the pancreas: a long term follow up survey of 11 patients. British Medical Journal 2 84-86.
43. Durig J, Fiedler W, de Wit M, Steffen M & Hossfeld DK 1996 Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha. Annals of Hematology 72 97-99.
44. Eastman RC, Carson RE, Orloff DG, Cochran CS, Perdue JF, Rechler MM, Lanau F, Roberts CT, Shapiro J & Roth J 1992 Glucose utilization in a patient with hepatoma and hypoglycaemia: assessment by a positron emission tomography. Journal of Clinical Investigation 89 1958-1963.
45. Elased KM, Taverne J & Playfair JH 1996 Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice. Clinical and Experimental Immunology 105 443-449.
46. England DM, Hochholzer L & McCarthy MJ 1989 Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. American Journal of Surgical Pathology 13 640-658.
47. Eriksson B, Oberg K & Skogseid B 1989 Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients. Acta Oncologia 28 373-377.
48. Fajans SS & Vinik AI 1989 Insulin-producing islet cell tumors. Endocrinology and Metabolism Clinics of North America 18 45-74.
49. Ferguson JM & Flinn J 1995 Intracranial meningioma with hepatic metastases and hypoglycaemia treated by selective hepatic arterial chemo-embolization. Australasian Radiology 39 97-99.
50. Field JB, Keen H, Johnson P & Herring B 1963 Insulin-like activity of nonpancreatic tumors associated with hypoglycemia. Journal of Clinical Endocrinology and Metabolism 23 1229-1236.
51. Fitzpatrick DR, Peroni DJ & Bielefeldt-Ohmann H 1995 The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. American Journal of Respiratory and Cellular Molecular Biology 12 455-460.
52. Fonseca V, Ames D & Ginsburg J 1989 Hypoglycaemia for 26 years due to an insulinoma. Journal of the Royal Society of Medicine 82 437-438.
53. Fradkin JE, Eastman RC, Lesniak MA & Roth J 1989 Specificity spillover at the hormone receptor - exploring its role in human disease. New England Journal of Medicine 320 640-645.
54. Froesch ER & Zapf J 1985 Insulin-like growth factors and insulin: comparative aspects. Diabetolosia 28 485-493.
55. Froesch ER, Burgi H, Ramseier EB, Bally P & Labhart A 1963 Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiologic significance an insulin assay with adipose tissue of increased precision and specificity. Journal of Clinical Investigation 42 1816-1834.
56. Fung JWK & Lam KSL 1995 Neurofibromatosis and insulinoma. Postgraduate Medical Journal 71 485-486.
57. Galbut DL & Markowitz AM 1980 Insulinoma: diagnosis, surgical management and long-term follow-up. American Journal of Surgery 139 682-690.
58. Galiber AK, Reading CC, Charboneau JW, Sheedy PF, James EM, Gorman B, Grant CS, van Heerden JA & Telander RL 1988 Localization of pancreatic insulinomas: comparison of pre- and intra-operative US with CT and angiography. Radiology 166 405-408.
59. Gama R, Marks V, Wright J & Teale JD 1995 Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma: the glucostatic importance of pancreatic glucagon. Clinical Endocrinology 43 117-120.
60. Gorden P, Hendricks CM, Kahn CR, Megyesi K & Roth J 1981 Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. A study of the tumor types. New England Journal of Medicine 305 1452-1455.
61. Corden P, Skarulis MC, Roach P, Comi RJ, Fraker DL, Norton JA, Alexander HR & Doppman JL 1995 Extensive personal experience: plasma proinsulin-like component in insulinoma: a 25-year experience. Journal of Clinical Endocrinology and Metabolism 80 2884-2887.
62. Graeme-Cook F, Nardi G & Compton CC 1990 Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas. American Journal of Clinical Pathology 93 273-276.
63. Grunberger G 1993 Insulin resistance in a case of coexisting insulinoma and type 2 diabetes. Acta Diabetologica 30 243-240.
64. Hale PJ, Djurup R, Baddeley RM & Nattrass M 1991 Insulin and proinsulin concentrations in patients with insulinoma before and after surgical treatment. Diabetes and Nutritional Metabolism 4 113-116.
65. Hampton S, Beyzavi K, Teale D & Marks V 1988 A direct assay for proinsulin in plasma and its application in hypoglycemia. Clinical Endocrinology 29 9-16.
66. Hattori N, Ishihara T, Saiki Y, Moridera K, Hino M, Ikekubo K & Kurahachi H 1994 Insulinoma wid normal plasma insulin concentrations and insulin/glucose ratios during hypoglycemic episodes. Internal Medicine 33 813-816.
67. Hayashi M, Floyd JC Jr, Pek S & Fajans SS 1977 Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism. Journal of Clinical Endocrinology and Metabolism 44 681-694.
68. Heik SCW, Kloppel G, Krone W, Iben G, Priebe K & Kuhnau J 1988 Hypoglykamie durch insulinom bei diabetes mellitus. Deutsche Medizinische Wochenschrift 113 1714-1717.
69. Hilali MM (AI), Majer RV & Penney O 1984 Hypoglycaemia in acute myelomonoblastic leukaemia: report of two cases and review of published work. British Medical Journal 289 1443-1444.
70. Hiramatsu K, Takahashi K, Kanemoto N & Arimori S 1987 A case of pheochromocytoma with transient hyperinsulinemia and reactive hypoglycemia. Japanese Journal of Medicine 26 88-90.
71. Hunter SJ, Daughaday WH, Callender ME, McKnight JA, McIlrath EM, Teale JD & Atkinson AB 1994 A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clinical Endocrinology 41 397-401.
72. Jacob A, Hauri Ch & Froesch ER 1968 Nonsuppressible insulin-like activity in human serum III: differentiation of two distinct molecules with nonsuppressible ILA. Journal of Clinical Investigation 47 2678-2688.
73. Kane LA, Grant CS, Nippoldt TB & Service FJ 1993 Insulinoma in a patient with NIDDM. Diabetes Care 16 1298-1300.
74. Katz LB, Aufses AH Jr, Ray field E & Mitty H 1986 Preoperative localization and intraoperative glucose monitoring in the management of patients with pancreatic insulinoma. Surgery Gynecology and Obstetrics 163 509-512.
75. Katz LE, Liu F, Baker B, Agus MS, Nunn SE, Hintz RL & Cohen P 1996 The effect of growth hormone treatment on the insulin-like growth factor axis in a child with non-islet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism 81 1141-1146.
76. Kavlie H & White TT 1972 Pancreatic islet beta-cell tumours and hyperplasia. Annals of Surgery 175 326-330.
77. Khaleeli A, Perumainar M, Speeding AV, Teale JD & Marks V 1991 Treatment of tumour induced hypoglycaemia with human growth hormone. Journal of the Royal Society of Medicine 85 303.
78. Knobel B, Rosman P & Czerniak A 1995 Endoscopie ultrasonography for the preoperative localization of insulinoma - a new, useful modality. Israeli Journal of Medical Science 31 365-367.
79. Krentz AJ, Mayer D, Ollilff SP, Bailey CJ, Libman LJ & Nattrass M 1996 Cryotherapy of hepatic metastases and regional perfusion with low-dose streptozotocin in the management of metastatic malignant insulinoma. Endocrine-Related Cancer 3341-345.
80. de Kreutzenberg SV, Riccio A, Dorella M, Avogaro A, Marescotti MC, Tiengo A & del Prato S 1994 Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action. European Journal of Clinical Investigation 25 360-367.
81. Krishna S, Waller DW, ter-Kuile F, Kwiatkowski D, Crawley J, Craddock CF, Nosten F, Chapman D, Brewster D, Holloway PA et al. 1994 Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 67-73.
82. Larsson C, Skogseid B, Oberg K, Nakamura Y & Nordenskjold M 1988 Multiple endocrine neoplasia type I gene maps to chromosome II and is lost in insulinoma. Nature 332 85-87.
83. Laurent J, Debry G & Floquet J 1971 Hypoglycaemic Tumours. Amsterdam: Excerpta Medica.
84. Liessi G, Pasquali C, D'Andrea A, Scandellari C & Pedrazzoli S 1992 MRI in insulinomas: preliminary findings. European Journal of Radiology 14 46-51.
85. Lightdale CJ, Botet JF, Woodruff JM & Brennan MF 1991 Localization of endocrine tumors of the pancreas with endoscopie ultrasonography. Cancer 68 1815-1820.
86. Losada J, Sarria R, Fernandez Val JF & Lopez Ariztegui MA 1995 DNA ploidy and PCNA index in pancreatic lesions producing hyperinsulinemic hypoglycemia. Journal of Surgical Oncology 59 14-17.
87. Lowe WL, Roberts CT, LeRoith D, Rojeski MT, Merimee TJ, Teng Fui S, Keen H, Arnold D, Mersey J, Gluzman S, Spratt D, Eastman RC & Roth J 1989 Insulin-like growth factor II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid. Journal of Clinical Endocrinology and Metabolism 69 1153-1159.
88. Lyall SS, Marieb NJ, Wise JK, Cornog JL, Neville EC & Felig P 1975 Hyperinsulinemic hypoglycemia associated with a neurofibrosarcoma. Archives of Internal Medicine 135 865-867.
89. MacDougall IC, Fleming S & Frier BM 1986 Hypoglycaemic coma associated with gastric carcinoma. Postgraduate Medical Journal 62 761-764.
90. McFadzean AJS & Yeung TT 1956 Hypoglycaemia in primary carcinoma of liver. Archives of Internal Medicine 98 720-736.
91. McFadzean AJS & Yeung TT 1969 Further observations of hypoglycaemia in hepatocellular carcinoma. American Journal of Medicine 47 220-226.
92. McGee GS, Kulaylat MM & Abumrad NN 1987 Defective glucose utilization in patients with functioning beta cell tumors persists after tumor excision. Annals of Surgery 206 449-457.
93. McIntyre I 1989 Amylinamide, bone conservation and pancreatic β-cells. Lancet ii 1026-1027.
94. Mahony SM & Tisdale MJ 1990 Metabolic effects of tumour necrosis factor alpha in NMRI mice. British Journal of Cancer 61 514-519.
95. Maioli M, Ciccarese M, Pacifico A, Tonolo G, Ganau A, Cossu S, Tanda F & Realdi G 1992 Familial insulinoma: description of two cases. Acta Diabetologica 29 38-40.
96. Makino H, Noda K, Inagaki Y, Horie H, Osegawa M, Kanatsuka A & Yoshida S 1985 Lactic acidosis and hypoglycemia associated with acute leukemia. Japanese Journal of Medicine 24 257-262.
97. Marks V 1976 Hypoglycaemia 2 - other causes. Clinical Endocrinology and Metabolism 5 769-782.
98. Marks V 1989 Diagnosis and differential diagnosis of hypoglycemia. Mayo Clinic Proceedings 64 1558-1561.
99. Marks V 1991 Hypoglycemia due to pancreatic causes. In The Endocrine Pancreas, pp 207-227. Ed E Samols. New York: Raven Press.
100. Marks V 1995 Hypoglycaemia - real and unreal, lawful and unlawful: the 1994 Banting Lecture. Diabetic Medicine 12 850-864.
101. Marks V 1997 Insulinomas and hypoglycaemia. In Clinical Endocrine Oncology, pp 383-386. Eds R Sheaves, PJ Jenkins & JAH Wass. Oxford: Blackwell Science.
102. Marks V & Rose FC 1964 Hypoglycaemia. Oxford: Blackwell.
103. Marks V & Rose FC 1981 Hypoglycaemia. Oxford: Blackwell.
104. Marks V & Samols E 1966 Hypoglycaemia of non-endocrine origin. Proceedings of the Royal Society of Medicine 59 338-340.
105. Marks V & Teale JD 1996 Investigation of hypoglycaemia. Clinical Endocrinology 44 133-136.
106. Marks V, Auld WHR & Barr JB 1965 Carcinoma of stomach and other non-pancreatic lesions as causes of spontaneous hypoglycaemia. British Journal of Surgery 52 925-928.
107. Marks V, Teale JD & Hampton SM 1992 Proinsulin assays in insulinomas. In Recent Advances on Hypoglycemia, Serono Symposia Publication 89, pp 145-159. Eds D Andreani, PJ Lefebvre, V Marks & G Tamburrano. New York: Raven Press.
108. Mårtensson H, Böttcher G, Sundler F & Nobin A 1990 Localization and peptide content of endocrine pancreatic tumors. Annals of Surgery 212 607-614.
109. Mathew PM, Young JM, Abu-Osba YK, Mulhern BD, Hammoudi S, Hamdan JA & S'di AR 1988 Persistent neonatal hyperinsulinism. Clinical Pediatrics 27 148-151.
110. Meeking DR, Steuer A, Cavan DA, Sönksen PH & Lowy CL 1997 A combination of subcutaneous growth hormone and octreotide for the treatment of malignant insulinoma. Endocrinology and Metabolism 4 265-266.
111. Megyesi K, Kahn CR, Roth J & Corden P 1974 Hypoglycemia in association with extrapancreatic tumors: demonstration of elevated plasma NSILA-s by a new radioreceptor assay. Journal of Clinical Endocrinology and Metabolism 38 931-934.
112. Megyesi K, Kahn CR, Roth J & Corden P 1975 Circulating NSILA-s in man - preliminary studies of stimuli in vivo and of binding to plasma components. Journal of Clinical Endocrinology and Metabolism 41 475-484.
113. Menegaux F, Schmitt G, Mercadier M & Chigot JP 1993 Pancreatic insulinomas. American Journal of Surgery 165 243-248.
114. Merlo C, Wimptheimer C, Muser J & Keller U 1992 Hypoglycemia and multiple myeloma. Schweizerische Medizinische Wochenschrift 122 1622-1626.
115. Mitchell ML, Ernesti M, Raben MS & Scaliter H 1965 Control of hypoglycemia with diazoxide and hormones. Annals of the New York Academy of Sciences 150 406-414.
116. Miyazaki K, Funakoshi A, Nishihara S, Wasada T, Koga A & Ibayashi H 1986 Aberrant insulinoma in the duodenum. Gastroenterology 90 1280-1285.
117. Moller N, Frystyk J, Skjaerbaek C, Pedersen HB, Christensen C, Schmilz O, Gee A, Gjedde A, Zapf J & Orskov H 1996 Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors. Diabetologia 39 1534-1535.
118. Moore NR, Rogers CE & Britton BJ 1995 Magnetic resonance imaging of endocrine tumours of the pancreas. British Journal of Radiology 68 341-347.
119. Nankervis A, Proietto J, Aitken P & Alford F 1985 Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma. Diabetologia 28 427-431.
120. Nauck M, Stockmann F & Creutzfeldt W 1990 Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients. European Journal of Clinical Investigation 20 15-28.
121. Nauck MA, Baum F, Seidensticker F, Roder M, Dinesen B & Creutzfeldt W 1997 A hyperinsulinaemic, sequentially euand hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma. European Journal of Clinical Investigation 27 109-115.
122. O'Brien TD, Butler AE, Roche PC, Johnson KH & Butler PC 1994 Islet amyloid polypeptide in human insulinomas. Diabetes 43 329-336.
123. Orci L, Vassalli J-D & Perrelett A 1988 The insulin factory. Scientific American 259 50-61.
124. Owens LV, Huth JF & Cance WG 1995 Insulinoma: pitfalls in preoperative localization. European Journal of Surgical Oncology 21 326-328.
125. Paineau J, Blanlocil Y, Legrand D, Pineau M, Letessier E, Charbonneau P & Visset J 1988 Postoperative hypoglycemia after excision of pheochromocytoma: a case. Presse Medicale 17 475-478.
126. Pasieka JL, McLeod MK, Thompson NW & Burney RE 1992 Surgical approach to insulinomas. Archives of Surgery 127 442-447.
127. Pavelic K & Popovic M 1981 Insulin and glucagon secretion by renal adenocarcinoma. Cancer 48 98-100.
128. Perdue JF, Gowan LK, Hudgins WR, Scheuermann J, Foster B & Northcutt Brown S 1991 Development of a specific radioimmunoassay for E domain containing forms of insulinlike growth factor II. In Molecular Biology and Physiology of Insulin, IGFs and their Receptors, pp 45-56. Eds MK Raizada & D LeRoith. New York: Plenum Publishing Corporation.
129. 111Inoctreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clinical Endocrinology 44 727-731.
130. Phuphanich S, Jacobs L, Poulos JE & Vesely DL 1995 Case report: Hypoglycemia secondary to a meningioma. American Journal of the Medical Sciences 309 317-321.
131. Pitre J, Soubrane O, Palazzo L & Chapuis Y 1996 Endoscopic ultrasonography for the preoperative localization of insulinomas. Pancreas 13 55-60.
132. Porte D Jr & Kahn SE 1989 Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction. Diabetes 38 1333-1336.
133. Redmon B, Pyzdrowski KL, Elson MK, Kay NE, Dalmasso AP & Nuttall FQ 1992 Hypoglycemia due to an insulin-binding monoclonal antibody in multiple myeloma. New England Journal of Medicine 326 994-998.
134. Rochet N, Blanche S, Carel JC, Fischer A, Deist FL, Griscelli C, van Obberghen E & Le Marchand-Brustel Y 1989 Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child. Diabetologia 32 167-172.
135. Rockett KA, Awburn MM, Rocket EJ & Clark IA 1994 Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. American Journal of Tropical Medicine and Hygiene 50 735-742.
136. Ron D, Powers AC, Pandian MR, Godine JE & Axelrod L 1989 Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia. Journal of Clinical Endocrinology and Metabolism 68 701-706.
137. Rosch T, Lightdale CJ, Boten JF, Boyce GA, Sivak MV Jr, Yasuda K, Heyder N, Palazzo L, Dancygier H & Schusdziarra V 1992 Localization of pancreatic endocrine tumors by endoscopic ultrasonography. New England Journal of Medicine 326 1721-1726.
138. Rother KI, Carney JA, Couce M, Charlesworth J & Butler PC 1995 Islet amyloid polypeptide in pancreatic tissue of children with persistent hyperinsulinemic hypoglycemia caused by primary islet hyperplasia and nesidioblastosis. Journal of Clinical Endocrinology and Metabolism 80 1956-1959.
139. Russell-Jones DL, Thomas SM, Simpson RD, Bevan PC & Bateman CJT 1990 The first reported case of hypoglycaemia as the presenting feature of invasive plasmacytoma with a paraprotein band and grossly elevated insulin levels. British Journal of Haematology 76 151-153.
140. Samaan NA, Pham FK, Sellin RV, Fernandez JF & Benjamin RS 1990 Successful treatment of hypoglycemia using glucagon in a patient with an extrapancreatic tumor. Annals of Internal Medicine 113 404-406.
141. Samols E 1965 Immunochemical aspects of insulin. In On the Nature and Treatment of Diabetes, pp 226-246. Eds RS Leibel & GA Wrenshall. Amsterdam: Excerpta Medica.
142. Samols E & Marks V 1963 Insulin assay in insulinomas. British Medical Journal i 507-510.
143. Sasaki H, Yamatani K, Tominaga M, Ebitani I, Yawata Y, Hara M & Kobayashi S 1980 Insulinoma-carcinoid syndrome as a paraneuroma. Biomedical Research 1 159-164.
144. Sata N, Kimura W, Kanazawa T & Muto T 1995 Malignant insulinoma causing liver metastases 8 years after the initial surgery: report of a case. Surgery Today 25 640-642.
145. Schumacher B, Lubke HJ, Frieling T, Strohmeyer G & Starke AA 1996 Prospective study on the detection of insulinomas by endoscopie ultrasonography. Endoscopy 28 273-276.
146. Service FJ, Dale AJD, Elveback LR & Jiang N-S 1976 Insulinoma - clinical and diagnostic features of 60 consecutive cases. Mayo Clinic Proceedings 51 417-429.
147. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC & Tager HS 1990 Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor II. Journal of Clinical Investigation 85 1672-1679.
148. Snowden JA, Greaves M & Page K 1994 Reversal of diabetes associated with escape of myeloma: evidence for inappropriate IGF-II secretion. British Journal of Haematology 87 202-204.
149. Stehouwer CD, Lems WF, Fischer HR, Hackeng WH & Naafs MA 1989 Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin). Acta Endocrinologica 121 34-40.
150. Stuart CA, Prince MJ, Peters EJ, Smith FE, Townsend CM & Poffenbarger PL 1986 Insulin receptor proliferation: a mechanism for tumor-associated hypoglycemia. Journal of Clinical Endocrinology and Metabolism 63 879-885.
151. Sturrock NDC, Selby C & Hosking DJ 1997 Spontaneous hypoglycaemia in a non-insulin-dependent diabetes mellitus patient with disseminated pancreatic carcinoma. Diabetic Medicine 14 324-326.
152. Svartberg J, Stridsberg M, Wilander E, Andersson DE & Eriksson B 1996 Tumour-induced hypoglycaemia in a patient with insulin-dependent diabetes mellitus. Journal of Internal Medicine 239 181-185.
153. Tasaka Y, Nakaya F, Matsumoto H, Odagiri R, Ohgawara H & Omori Y 1993 Tumor and serum levels of proinsulin and insulin in insulinoma patients. Endocrine Journal 40 245-248.
154. Taylor SI, Barbetti F, Accili D, Roth J & Corden P 1989 Syndromes of autoimmunity and hypoglycemia: autoantibodies directed against insulin and its receptor. Endocrinology and Metabolism Clinics of North America 18 123-143.
155. Teale JD & Marks V 1986 The measurement of insulin-like growth factor I - clinical applications and significance. Annals of Clinical Biochemistry 23 413-424.
156. Teale JD & Marks V 1990 Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulinlike growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia. Clinical Endocrinology 33 87-98.
157. Teale JD & Marks V 1998 Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH). Clinical Endocrinology (In Press).
158. Teale JD, Pearse AG & Marks V 1987 The measurement of insulin, C-peptide and β-hydroxybutyrate in the differential diagnosis of spontaneous hypoglycaemia. In Hypoglycaemia, pp 281-282. Eds D Andreani, V Marks & PJ Lefebvre. New York: Raven Press.
159. Teale JD, Starkey BJ, Marks V, Hampton SM, Robinson J, Fisher RA & Levine DF 1989 The prevalence of factitious hypoglycaemia due to sulphonylurea abuse in the UK: a preliminary report. Practical Diabetes 6 177-178.
160. Teale JD, Blum WF & Marks V 1992 Alleviation of non-islet cell tumour associated hypoglycaemia through the restorative effect of growth hormone therapy on plasma levels of insulinlike growth factor binding protein-3. Annals of Clinical Biochemistry 29 314-323.
161. Thakker RV 1997 Multiple endocrine neoplasia type 1. In Clinical Endocrine Oncology, pp 433-444. Eds R Sheaves, P Jenkins & JAH Wass. Oxford: Blackwell Science.
162. Thompson GB, Service FJ, van Heerden JA, Carney JA, Charboneau JW, O'Brien PC & Grant CS 1993 Reoperative insulinomas 1927 to 1992: an institutional experience. Surgery 114 1196-1206.
163. Thompson NW, Czako PF, Fritts LL, Bude R, Bansal R, Nostrant TT & Scheiman JM 1994 Role of endoscopie ultrasonography in the localization of insulinomas and gastrinomas. Surgery 116 1131-1138.
164. Trivedi N, Mithal A, Sharma AK, Mishra SK, Pandey R, Trivedi B & Daughaday WH 1995 Non-islet cell tumour induced hypoglycaemia with acromegaloid facial and acral swelling. Clinical Endocrinology 42 433-435.
165. Valette PJ & Souquet JC 1989 Pancreatic islet cell tumors metastatic to the liver: treatment hy hepatic artery chemoembolization. Hormone Research 32 77-79.
166. Vinik AI, Delbridge L, Moattari R, Cho K & Thompson N 1991 Transhepatic portal vein catheterization for localization of insulinomas: a ten-year experience. Surgery 109 1-11.
167. Walters EG, Tavar JM, Denton RM & Walters G 1987 Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease. Lancet i 241-243.
168. Wanebo HJ, Schessinger I & Tashima CK 1966 Severe hypoglycemia associated with terminal lymphomas. Cancer 19 1451-1459.
169. Wasada T, Eguchi Y, Takayama S, Yao K, Hirata Y & Ishii S 1989 Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence for monoclonal insulin autoantibodies. Diabetes Care 12 147-150.
170. Watson RGP, Johnston CF, O'Hare MMT, Anderson JR, Wilson BG, Collins JSA, Sloan JM & Buchanan KD 1989 The frequency of gastrointestinal endocrine tumours in a well-defined population - Northern Ireland 1970-1985. Quarterly Journal of Medicine 72 647-657.
171. Wells JL, Heath DA & West RJ 1990 Hepatic artery embolization in the treatment of intractable hypoglycaemia. Journal of the Royal Society of Medicine 83 592-593.
172. Wright J, Abolfathi A, Penman E & Marks V 1980 Pancreatic somatostatinoma presenting with hypoglycaemia. Clinical Endocrinology 12 603-608.
173. Wu J-C, Daughaday WH, Lee S-D, Hsiao TS, Chou C-K, Lin H-D, Tsai Y-T & Chiang BN 1988 Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. Journal of Laboratory and Clinical Medicine 112 589-594.
174. Yoshikawa K & Wakasa H 1980 Hypoglycemia associated with aberrant insulinoma: a case report of 16 years follow-up. Tohoku Journal of Experimental Medicine 132 17-29.
175. Younus S, Soterakis J, Sossi AJ, Chawla SK & LoPresti PA 1977 Hypoglycemia secondary to metastases to the liver: a case report and review of the literature. Gastroenterology 72 334-337.
176. Zimmer T, Stolzel U, Bader M, Koppenhagen K, Hamm B, Buhr H, Riecken EO & Wiedenmann B 1996 Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 39 562-568.